Doxorubicin loaded singlet-oxygen producible polymeric micelle based on chlorine e6 conjugated pluronic F127 for overcoming drug resistance in cancer

Biomaterials

Volumn 35, Issue 27, 2014, Pages 7963-7969

  Park, Hyung ^a   Park, Wooram ^a   Na, Kun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cancer; Doxorubicin; Drug resistance; Photochemical internalization (PCI); Photosensitizer

Indexed keywords

CELL MEMBRANES; CHEMOTHERAPY; DRUG DOSAGE; GAS GENERATORS; MICELLES; OXYGEN; PHOTOSENSITIZERS; POLYMERS;

AMPHIPHILIC CO-POLYMERS; AQUEOUS ENVIRONMENT; CANCER; CANCER CHEMOTHERAPY; DOXORUBICIN; DRUG RESISTANCE; LIPID PEROXIDATION; PHOTOCHEMICAL INTERNALIZATION;

DISEASES;

AMPHOPHILE; CHLORINE DERIVATIVE; DOXORUBICIN; MALONALDEHYDE; POLOXAMER; SINGLET OXYGEN; CHLORIN E6; MICELLE; POLYMER; PORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CANCER THERAPY; CELL DAMAGE; CELL LYSATE; CELL MEMBRANE; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONJUGATE; CONTROLLED STUDY; DISPERSION; DRUG UPTAKE; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIPID PEROXIDATION; MICELLE; MOUSE; NICK END LABELING; NONHUMAN; PARTICLE SIZE; PERMEABILITY; PHOTOCHEMICAL INTERNALIZATION; POLYMERIZATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE CHARGE; SUSTAINED DRUG RELEASE; TUMOR GROWTH; ANIMAL; CELL DEATH; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; ENDOCYTOSIS; HUMAN; TUMOR CELL LINE;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENDOCYTOSIS; HUMANS; LIPID PEROXIDATION; MICE; MICELLES; POLOXAMER; POLYMERS; PORPHYRINS; SINGLET OXYGEN;

EID: 84903476191     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.05.063     Document Type: Article

References (31)

1. Cole S., Bhardwaj G., Gerlach J., Mackie J., Grant C., Almquist K., et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258:1650-1654.
2. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002, 2:48-58.
3. Longley D.B., Johnston P.G. Molecular mechanisms of drug resistance. JPathol 2005, 205:275-292.
4. Lee Y., Graeser R., Kratz F., Geckeler K.E. Paclitaxel-loaded polymer nanoparticles for the reversal of multidrug resistance in breast cancer cells. Adv Funct Mater 2011, 21:4211-4218.
5. Lehnert M. Clinical multidrug resistance in cancer: a multifactorial problem. Eur J Cancer 1996, 32:912-920.
6. Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., Zhuo R., et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009, 323:1718-1722.
7. Bansal T., Akhtar N., Jaggi M., Khar R.K., Talegaonkar S. Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation. Drug Discov Today 2009, 14:1067-1074.
8. Kievit F.M., Zhang M. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater 2011, 23:H217-H247.
9. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 1989, 86:695-698.
10. Robey R.W., To K.K., Polgar O., Dohse M., Fetsch P., Dean M., et al. ABCG2: a perspective. Adv Drug Deliv Rev 2009, 61:3-13.
11. Gillmeister M.P., Betenbaugh M.J., Fishman P.S. Cellular trafficking and photochemical internalization of cell penetrating peptide linked cargo proteins: a dual fluorescent labeling study. Bioconjug Chem 2011, 22:556-566.
12. Lee C.S., Park W., Park S.J., Na K. Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption. Biomaterials 2013, 34:9227-9236.
13. Park S.J., Park W., Na K. Photo-activatable ternary complex based on a multifunctional shielding material for targeted shRNA delivery in cancer treatment. Biomaterials 2013, 34:8991-8999.
14. Selbo P.K., Weyergang A., Eng M.S., Bostad M., Mælandsmo G.M., Høgset A., et al. Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug. JControl Release 2012, 159:197-203.
15. Berg K., Selbo P.K., Prasmickaite L., Tjelle T.E., Sandvig K., Moan J., et al. Photochemical internalization a novel technology for delivery of macromolecules into cytosol. Cancer Res 1999, 59:1180-1183.
16. Jin H., Lovell J.F., Chen J., Lin Q., Ding L., Ng K.K., et al. Mechanistic insights into LDL nanoparticle-mediated siRNA delivery. Bioconjug Chem 2011, 23:33-41.
17. Matsushita-Ishiodori Y., Morinaga M., Watanabe K., Ohtsuki T. Near-infrared light-directed RNAi using a photosensitive carrier molecule. Bioconjug Chem 2013, 24:1669-1673.
18. Nishiyama N., Iriyama A., Jang W.D., Miyata K., Itaka K., Inoue Y., et al. Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer. Nat Mater 2005, 4:934-941.
19. Park S.J., Na K. The transfection efficiency of photosensitizer-induced gene delivery to human MSCs and internalization rates of EGFP and Runx2 genes. Biomaterials 2012, 33:6485-6494.
20. Høgset A., Prasmickaite L., Selbo P.K., Hellum M., Engesæter B.Ø., Bonsted A., et al. Photochemical internalisation in drug and gene delivery. Adv Drug Deliv Rev 2004, 56:95-115.
21. Selbo P.K., Weyergang A., Høgset A., Norum O.-J., Berstad M.B., Vikdal M., et al. Photochemical internalization provides time-and space-controlled endolysosomal escape of therapeutic molecules. JControl Release 2010, 148:2-12.
22. Park H., Na K. Conjugation of the photosensitizer Chlorin e6 to pluronic F127 for enhanced cellular internalization for photodynamic therapy. Biomaterials 2013, 34:6992-7000.
23. Lee S., Isabelle M.E., Gabally-Kinney K.L., Pogue B.W., Davis S.J. Dual-channel imaging system for singlet oxygen and photosensitizer for PDT. Biomed Opt Express 2011, 2:1233-1242.
24. Dai J., Lin S., Cheng D., Zou S., Shuai X. Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew Chem Int Ed Engl 2011, 50:9404-9408.
25. Acharya S., Sahoo S.K. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 2011, 63:170-183.
26. Choi Y., Weissleder R., Tung C.H. Selective antitumor effect of novel protease-mediated photodynamic agent. Cancer Res 2006, 66:7225-7229.
27. Yoon H.Y., Koo H., Choi K.Y., Lee S.J., Kim K., Kwon I.C., et al. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 2012, 33:3980-3989.
28. Yim H., Na K. Polycationic nanodrug covered with hyaluronic acid for treatment of P-glycoprotein overexpressing cancer cells. Biomacromolecules 2010, 11:2387-2393.
29. Goldstein B.D., Harber L.C. Erythropoietic protoporphyria: lipid peroxidation and red cell membrane damage associated with photohemolysis. JClin Invest 1972, 51:892-902.
30. Lu H.L., Syu W.J., Nishiyama N., Kataoka K., Lai P.S. Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance invivo. JControl Release 2011, 155:458-464.
31. Kaminskas L.M., McLeod V.M., Kelly B.D., Cullinane C., Sberna G., Williamson M., et al. Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models. Mol Pharm 2012, 9:422-432.